super natural killer cell therapy (Hangzhou Qihan Biotech)

N/A

Report date: 2025/06/11 10:38:24

Base Information

Drug Namesuper natural killer cell therapy (Hangzhou Qihan Biotech)
Drug Alias Namehuman induced pluripotent stem cells (hiPSC) derived super natural killer cell therapy (Hangzhou Qihan Biotech)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cells stimulantsImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Qihan Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Qihan Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A